Literature DB >> 15196857

Depth of cervical stromal invasion as a prognostic factor after radical surgery for early stage cervical cancer.

Mohamed Allam1, Cynthia Feely, David Millan, James Nevin, Jonathan Davis, Nadeem Siddiqui.   

Abstract

INTRODUCTION: In the United Kingdom, the Royal College of Pathologists have issued guidelines detailing how the depth of stromal invasion (DOI) in cervical cancer should be measured as a percentage of the overall cervical radius in millimeters. Several studies have found the assessment of the depth of stromal invasion by cancer of the cervix to be of prognostic value. These studies did not take into account patients whose diagnostic procedures required removal of much tumor (large loop excision of the transformation zone [LLETZ] and knife cone biopsies). Furthermore, the Royal College of Pathologists guidelines do not address this issue.
MATERIALS AND METHODS: Over the period of 6 years, 228 women had radical hysterectomy (RH) for stage Ib/IIa cervical cancer. The percentage of the depth of stromal invasion was measured according to the Royal College of Pathologist's guidelines in the UK. Patients who had large loop excision of the transformation zone and knife cone biopsies were excluded (91 patients).
RESULTS: A Cox regression analysis showed that when nodal involvement, depth of stromal invasion, endothelial lined space invasion (ELSI), and tumor type were fitted simultaneously, only nodal involvement remained as a marker of adverse outcome.
CONCLUSIONS: We recommend that when the DOI is measured, account should be taken of the LLETZ/knife cone biopsy size. A randomized controlled trial, which concludes that DOI is an independent prognostic factor, is needed. Until this is properly evaluated, we feel that including DOI as an essential part of the standard pathological report is not warranted.

Entities:  

Mesh:

Year:  2004        PMID: 15196857     DOI: 10.1016/j.ygyno.2004.02.029

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

Review 1.  Fertility-Sparing Treatment for Early-Stage Cervical Cancer ≥ 2 cm: A Problem with a Thousand Nuances-A Systematic Review of Oncological Outcomes.

Authors:  Carlo Ronsini; Maria Cristina Solazzo; Nicolò Bizzarri; Domenico Ambrosio; Marco La Verde; Marco Torella; Raffaela Maria Carotenuto; Luigi Cobellis; Nicola Colacurci; Pasquale De Franciscis
Journal:  Ann Surg Oncol       Date:  2022-09-05       Impact factor: 4.339

Review 2.  Current Standards in the Management of Early and Locally Advanced Cervical Cancer: Update on the Benefit of Neoadjuvant/Adjuvant Strategies.

Authors:  Yuedan Zhou; Elie Rassy; Alexandre Coutte; Samir Achkar; Sophie Espenel; Catherine Genestie; Patricia Pautier; Philippe Morice; Sébastien Gouy; Cyrus Chargari
Journal:  Cancers (Basel)       Date:  2022-05-16       Impact factor: 6.575

3.  Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study.

Authors:  Nicolò Bizzarri; Luigi Pedone Anchora; Gian Franco Zannoni; Vittoria Carbone; Matteo Bruno; Camilla Fedele; Valerio Gallotta; Vito Chiantera; Giacomo Avesani; Benedetta Gui; Francesco Fanfani; Anna Fagotti; Giovanni Scambia; Gabriella Ferrandina
Journal:  Br J Cancer       Date:  2021-04-14       Impact factor: 7.640

4.  Histological type-specific prognostic factors of cervical small cell neuroendocrine carcinoma, adenocarcinoma, and squamous cell carcinoma.

Authors:  Suthida Intaraphet; Nongyao Kasatpibal; Mette Søgaard; Surapan Khunamornpong; Jayanton Patumanond; Anchalee Chandacham; Imjai Chitapanarux; Sumalee Siriaunkgul
Journal:  Onco Targets Ther       Date:  2014-07-01       Impact factor: 4.147

5.  MRI-based radiomics analysis improves preoperative diagnostic performance for the depth of stromal invasion in patients with early stage cervical cancer.

Authors:  Jing Ren; Yuan Li; Jun-Jun Yang; Jia Zhao; Yang Xiang; Chen Xia; Ying Cao; Bo Chen; Hui Guan; Ya-Fei Qi; Wen Tang; Kuan Chen; Yong-Lan He; Zheng-Yu Jin; Hua-Dan Xue
Journal:  Insights Imaging       Date:  2022-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.